久久天堂av综合合色蜜桃网-亚洲精品自在在线观看-欧美大屁股xxxx-熟妇人妻一区二区三区四区-色五月丁香五月综合五月

首頁 >> 產品展示 >> 生化試劑 >> 海外試劑代購 >> 25200Goat-anti-Human IgG (H L)*

Goat-anti-Human IgG (H L)*

簡要描述:Goat-anti-Human IgG (H L)*
新產品的亮點包括:抗原修復,Formvar和碳支撐膜網格增加1500多種新厚度,產品僅由Electron Microscopy Sciences提供:Nightsea; LatticeAx; Lynx II Tissue Processor; Cryo工作站;公司; EMS-UAR,EMS Cryo-Sem制備系統等等。

  • 產品型號:25200
  • 廠商性質:經銷商
  • 更新時間:2019-05-08
  • 訪  問  量:698
詳細資料

Goat-anti-Human IgG (H L)*

 

Goat-anti-Human IgG (H&L)

 Particle SizeCat. #ml Price Cat. #ml Price 
4-8°CUltraSmall252001.5399.00Add to Cart25201.6229.00Add to Cart
4-8°CEM-grade 6nm252032.5399.00Add to Cart252041.0229.00Add to Cart
4-8°CEM-grade 10nm252082.5399.00Add to Cart252091.0229.00Add to Cart
4-8°CEM-grade 15nm252123.5399.00Add to Cart252131.4229.00Add to Cart
4-8°CEM-grade 25nm252153.5399.00Add to Cart252161.4229.00Add to Cart

 

 

Goat-anti-Human IgG (H L)*

 

 

arrow12Cross Adsorbed Products

Cross reactivity can be a problem when working with primary antibodies sourced from animal species that are evolutionary closely related to the source of tissues or cells that antigens are to be detected in.

An example is using a mouse monoclonal on rat tissue. With many monoclonal antibodies of mouse origin and some of rat, and the prevailing animal cells and tissues being used in studies likewise originating from rat or mouse, it often happens that cross reactivity occurs, leading to false positive results.

A second problem that derives from cross-reactivity occurs in double labeling, when using primary antibodies from closely related animal sources. With this in mind, Aurion has developed two series of new conjugates:

如果你對25200Goat-anti-Human IgG (H L)*感興趣,想了解更詳細的產品信息,填寫下表直接與廠家聯系:

留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7

蘇州螞蟻淘生物科技有限公司(www.taozhekouba.cn)主營產品:海外生命科學試劑儀器代購

總訪問量:246015  管理登陸  技術支持:化工儀器網  sitemap.xml

版權所有 © 2024 蘇州螞蟻淘生物科技有限公司  ICP備案號:蘇ICP備17049038號-2
在線留言 聯系方式 二維碼

服務熱線

18915418616

掃一掃,關注我們